About Ethoderm
Ethoderm is a company based in Henderson (United States) founded in 2022. Ethoderm offers products and services including Transdermal Delivery Technology. Ethoderm operates in a competitive market with competitors including PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others.
- Headquarter Henderson, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ethoderm Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ethoderm
Ethoderm offers a comprehensive portfolio of products and services, including Transdermal Delivery Technology.
Platform for topical gel-based delivery of therapeutics to treat chronic diseases effectively.
People of Ethoderm
Unlock access to complete
Unlock access to complete
Scientific Team
3 people
Advisor Team
3 people
Leadership Team
2 people
COO Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Ethoderm
Detailed funding history for Ethoderm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ethoderm
Investment portfolio details for Ethoderm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ethoderm
Detailed financials for Ethoderm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ethoderm Comparisons
Peer comparison for Ethoderm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ethoderm
Ethoderm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| Locked | Locked | Locked |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| Locked | Locked | Locked |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for ophthalmology and rheumatology diseases are manufactured.
|
|
| Locked | Locked | Locked |
Patented drug delivery technology is developed for bioactive molecules.
|
|
| Locked | Locked | Locked |
Drug-releasing medical devices and medicines are developed with InCube technology.
|
Detailed competitors of Ethoderm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ethoderm
Complete news archive for Ethoderm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ethoderm
Ethoderm was founded in 2022.
Ethoderm is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.
Ethoderm was founded in 2022 and is based in Henderson, United States. Operations are focused on the biotechnology sector, where transdermal drug delivery systems are developed to address chronic diseases. Research and innovation efforts are directed toward improving drug administration methods through skin-based technologies. The companys domain is etoderm.com, supporting its activities in pharmaceutical advancements for long-term health conditions.
Ethoderm's top competitors include PanTher Therapeutics, PolyPid and Lexaria Bioscience.
Ethoderm offers Transdermal Delivery Technology.